rivaroxaban in patients stabilized after a st-segment elevation myocardial infarction - results from...

Upload: astri-ggamjong-xiao-lu

Post on 02-Jun-2018

212 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction - Results From the ATLAS ACS-2TIMI-51 Trial (Anti-Xa Therapy to Low

    1/7

  • 8/10/2019 Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction - Results From the ATLAS ACS-2TIMI-51 Trial (Anti-Xa Therapy to Low

    2/7

  • 8/10/2019 Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction - Results From the ATLAS ACS-2TIMI-51 Trial (Anti-Xa Therapy to Low

    3/7

  • 8/10/2019 Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction - Results From the ATLAS ACS-2TIMI-51 Trial (Anti-Xa Therapy to Low

    4/7

  • 8/10/2019 Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction - Results From the ATLAS ACS-2TIMI-51 Trial (Anti-Xa Therapy to Low

    5/7

  • 8/10/2019 Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction - Results From the ATLAS ACS-2TIMI-51 Trial (Anti-Xa Therapy to Low

    6/7

  • 8/10/2019 Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction - Results From the ATLAS ACS-2TIMI-51 Trial (Anti-Xa Therapy to Low

    7/7